Skip to content
Colorectal Cancer Clinical Trials

Alabama

Colorectal cancer clinical trials in Alabama

17 colorectal cancer studies are recruiting participants at sites in 5 cities across Alabama as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Alabama city with a recruiting study

Birmingham (12), Mobile (5), Dothan (2), Homewood (1), Tuscaloosa (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Alabama

Basic details from each study's public record (the 12 most recently updated of 17). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Birmingham
    Registry record
    NCT07488676 · updated
  2. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Recruiting in
    Mobile · Tuscaloosa
    Registry record
    NCT07228832 · updated
  3. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Recruiting in
    Homewood
    Registry record
    NCT07446322 · updated
  4. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Mobile
    Registry record
    NCT05174169 · updated
  5. Family Communications After Genetic Testing

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Birmingham
    Registry record
    NCT07143487 · updated
  6. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Recruiting in
    Birmingham
    Registry record
    NCT04657068 · updated
  7. Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population

    • No phase
    • Ages 45 to 84
    • All sexes
    Sponsor
    Jubaan Ltd.
    Recruiting in
    Dothan · Mobile
    Registry record
    NCT07623902 · updated
  8. 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Radiopharm Theranostics, Ltd
    Recruiting in
    Dothan
    Registry record
    NCT07189871 · updated
  9. PRE-ISPY Phase I/II Oncology Platform Program

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    QuantumLeap Healthcare Collaborative
    Recruiting in
    Birmingham
    Registry record
    NCT05868226 · updated
  10. DESTINY-PANTUMOUR04

    • Observational
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Recruiting in
    Birmingham
    Registry record
    NCT07124000 · updated
  11. ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Guardant Health, Inc.
    Recruiting in
    Birmingham
    Registry record
    NCT05059444 · updated
  12. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Recruiting in
    Birmingham
    Registry record
    NCT04851119 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Alabama on ClinicalTrials.gov.

Ask about studies in Alabama

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call